109353 ⎘
Active agents used in cell culture processes, e.g. differentation; Cytokines; Chemokines Interferons [IFN]
Method for preparing dendritic cell, dendritic cell prepared thereby, and use thereof
#302POLYVALENT ANTI-TUMOR FIBROBLAST VACCINE
#303BIOLOGICALLY OPTIMIZED ADULT MESENCHYMAL STEM CELLS
#304Fusion molecule based on novel TAA variant
#305β-glucan methods and compositions that affect the tumor microenvironment
#306Mature dendritic cell compositions and methods for culturing same
#307Mature dendritic cell compositions and methods for culturing same
#308Compositions and methods for producing dendritic cells
#309COMPOSITIONS FOR THE PREPARATION OF MATURE DENDRITIC CELLS
#310Method for proliferation of antigen-specific T cells
#311METHODS FOR TESTING T CELL PRIMING EFFICACY IN A SUBJECT
#312Modified natural killer cells, compositions and uses thereof
#313REGULATORY MACROPHAGES AS A CELL-BASED IMMUNOMODULATORY THERAPY IN PULMONARY HYPERTENSION AND RIGHT VENTRICULAR DYSFUNCTION
#314Fusion molecule based on novel TAA variant
#315Stem cell microparticles and miRNA
#316Induction medium and methods for stem cell culture and therapy
#317Muscle stem cell in vitro culture method and application
#318System for immunotherapy targeting tumor propagation and progression
#319COMPOSITION AND METHODS OF CULTURE SUPERNATANT OF KHYG-1 CELLS
#320Dendritic Cell Compositions and Methods
#321Induction medium and methods for stem cell culture and therapy
#322Methods for in vitro memory B cell differentiation and transduction with VSV-G pseudotyped viral vectors
#323Induced dendritic cells and uses thereof
#324Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
#325METHOD OF PRODUCING MICROPARTICLES
#326Co-differentiation of monocytes from allogeneic donors
#327RNA preparations comprising purified modified RNA for reprogramming cells
#328Method for cellular RNA expression
#329Compositions for inducing or suppressing an immune response
#330METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES
#331Cell populations having immunoregulatory activity, method for isolation and uses
#332Industrial preparations of natural killer (NK) cells and injections containing NK cells
#333IL-9 secreting CD8+ Tc9 cells and methods of treating cancer
#334STEM CELL MICROPARTICLES
#335Composition for maturing dendritic cells, and method for preparing antigen-specific dendritic cells using same
#336Mature dendritic cell compositions and methods for culturing same
#337Proliferating agent for monocyte, culture medium for proliferating monocyte, method for producing monocyte, method for producing dendritic cell, and method for producing dendritic cell vaccine
#338CD4+ CD25+ T-CELLS ACTIVATED TO A SPECIFIC ANTIGEN
#339Compositions for the preparation of mature dendritic cells
#340Method for attenuating immune response using mesenchymal stem cells and cytokines
#341Method for proliferation of antigen-specific T cells
#342Ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases
#343Methods of expanding and assessing B cells and using expanded B cells to treat disease
#344Dendritic cells obtained from induced pluripotent stem cells (iPSCs)
#345Mature dendritic cell compositions and methods for culturing same
#346T-cell therapy to neurodegenerative diseases
#347Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
#348System for immunotherapy targeting tumor propagation and progression
#349Engineered dendritic cells and uses for the treatment of cancer
#350Methods and compositions for expanding and stabilizing natural regulatory T cells
#351Activated mesenchymal stem cells for wound healing and impaired tissue regeneration
#352INHIBITORS OF LL-37 MEDIATED IMMUNE REACTIVITY TO SELF NUCLEIC ACIDS
#353MUTZ-3 dendritic cells
#354STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF
#355Mature Dendritic Cell Compositions and Methods of Culturing Same
#356ADMINISTRATION OF DENDRITIC CELLS PARTIALLY MATURED IN VITRO FOR THE TREATMENT OF TUMORS
#357Process for production of natural killer cells
#358Dendritic cell compositions and methods
#359Engineered Dendritic Cells and Uses for the Treatment of Cancer
#360DIFFERENTIATION OF PRIMATE PLURIPOTENT STEM CELLS TO HEMATOPOIETIC LINEAGE CELLS
#361Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)
#362Ex-vivo treatment of peripheral plasmacytoid dendritic cells with IFN-lambda
#363TUMOR SUPPRESSION USING PLACENTAL STEM CELLS
#364METHODS FOR TREATING TUMORS AND CANCEROUS TISSUES
#365Manufacturing method of immune killer cells
#366Dendritic cell vaccines
#367Dendritic Cells
#368Marker genes for regulatory T cells from human blood
#369Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection
#370Dendritic cell vaccines for asparaginyl-β-hydroxylase expressing tumors
#371Therapeutical composition containing dentritic cells and use thereof
#372ACTIVATED MESENCHYMAL STEM CELLS FOR THE PREVENTION AND REPAIR OF INFLAMMATORY STATES
#373Inhibitors of LL-37 Mediated Immune Reactivity to Self Nucleic Acids
#374STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF
#375EX VIVO, FAST AND EFFICIENT PROCESS TO OBTAIN ACTIVATED ANTIGEN-PRESENTING CELLS THAT ARE USEFUL FOR THERAPIES AGAINST CANCER AND IMMUNE SYSTEM-RELATED DISEASES
#376Methods for producing dendritic cells with an siRNA that interferes with MAPKAPK2 expression
#377Compositions for the preparation of mature dendritic cells
#378TH-17 CELLS
#379Manufacturing Method of Activated Lymphocytes for Immunotherapy
#380VIRAL LATENCY MODEL
#381Fusion molecule based on novel TAA variant
#382Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)
#383INTERFERON-alpha REGULATOR
#384Reagents and Methods for Engaging Unique Clonotypic Lymphocyte Receptors
#385METHOD OF MODULATING CELLULAR ACTIVITY AND AGENTS USEFUL FOR SAME
#386Treatment of inflammatory bowel disease
#387ANTI-CD8 ANTIBODIES BLOCK PRIMING OF CYTOTOXIC EFFECTORS AND LEAD TO GENERATION OF REGULATORY CD8+ T CELLS
#388MATURATION OF DENDRITIC CELLS
#389Differentiation of primate pluripotent stem cells to hematopoietic lineage cells
#390Kit containing stem cells and cytokines for use in attenuating immune responses
#391INDUCTION OF DENDRITIC CELL DEVELOPMENT WITH MACROPHAGE-COLONY STIMULATING FACTOR (M-CSF) RECEPTOR LIGANDS
#392Cell Population Having Immunoregulatory Activity, Method for Isolation and Uses
#393Engineered Dendritic Cells and Uses for the Treatment of Cancer
#394Immune potentiating compositions of cancer cells
#395Method for treating disseminated cancer
#396Dendritic cell stimulatory factor
#397Dendritic cell compositions and methods
#398Dendritic cells, uses therefor, and vaccines and methods comprising the same
#399Methods of Cell Therapy, Neurogenesis and Oligodendrogenesis
#400Cd4+ Cd25+ T-cells activated to a specific antigen
#401Autologous T Cell Manufacturing Processes
#402Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)
#403COMPOSITIONS AND METHODS FOR PRIMING MONOCYTIC DENDRITIC CELLS AND T CELLS FOR TH-1 RESPONSE
#404Method for Activating Cd4 Cell
#405Method for Activating Cd8 T Cells
#406Tumor suppression using placental stem cells
#407Mature Dendritic Cell Compositions and Methods of Culturing Same
#408Method of modulating cellular activity and agents useful for same
#409Dendritic Cells Generated Using GM-CSF and Interferon Alpha and Loaded with Heat-Treated and Killed Cancer Cells
#410Therapeutical Composition Containing Dentritic Cells And Use Thereof
#411Method for the direct culture of dendritic cells without a preceding centrifugation step
#412PURGING OF CELLS USING VIRUSES
#413Medicaments for the immunotherapy of malignant tumors
#414Mature dendritic cell compositions and methods for culturing same
#415Vaccine composition comprising Flt3-ligand
#416Transplant acceptance inducing cells of monocytic origin and their preparation and use
#417Stromal antigen-presenting cells and use thereof
#418Growth of human dendritic cells for cancer immunotherapy in closed system using microcarrier beads
#419Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations
#420Use of dendritic cells (DCs) expressing interleukin 12 (IL-12)
#421Mature dendritic cell compositions and methods for culturing same
#422Administration of dendritic cells partially matured in vitro for the treatment of tumors
#423Neural transplantation using pluripotent neuroepithelial cells
#424Methods for treating tumors and cancerous tissues
#425Monocyte-derived dendritic cell subsets
#426Compositions and methods for priming monocytic dendritic cells and t cells for th-1response
#427Conversion of liver stem and progenitor cells to pancreatic functional cells
#428Generation and use of new types of dendritic cells
#429Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#430Cell culture medium